Endonovo Therapeutics seeks Intensive Care Unit Partners for Investigational Adjunctive Treatment for Severe Respiratory Inflammatory Complications for COVID-19 Patients.
25 mars 2020 08h00 HE
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, March 25, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announces the intent to distribute of SofPulse®...
Global Generic Oncology Sterile Injectables Market to Surpass US$ 23.4 Billion by 2025 - Coherent Market Insights
24 mai 2018 08h55 HE
|
Coherent Market Insights
SEATTLE, May 24, 2018 (GLOBE NEWSWIRE) -- The global generic oncology sterile injectable market was valued at US$ 9,838.0 million in 2017 and is projected to exhibit a CAGR of 11.4% over the...
Response to Novel Immune Therapy for Ulcerative Colitis Associated with Genetic and Immune Biomarkers
03 oct. 2017 12h16 HE
|
Qu Biologics
VANCOUVER, British Columbia , Oct. 03, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...
Hemispherx Encouraged by Cytokine Biomarker Discovery Which May Lead to a Diagnostic for Chronic Fatigue Syndrome
04 août 2017 08h30 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, Aug. 04, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) said today that a new study led by a team of researchers from Stanford University may provide the basis for a...